Seeking Alpha

Shares of MAP Pharmaceuticals (MAPP -5.3%) slide today after the company priced its secondary...

Shares of MAP Pharmaceuticals (MAPP -5.3%) slide today after the company priced its secondary offering of 3.88M shares at $13.40, a 5% discount to yesterday's close. The company intends to use the proceeds to bring its investigational migraine drug Levadex to market, as well as for other general corporate purposes.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)